Point-of-Care Glucose Testing Industry Status, Analysis and Business Outlook 2019 - 2027| key player Roche Diabetes Care, LifeScan IP Holdings, LLC.

Point-of-Care Glucose Testing Market: Introduction
• Point-of-care testing for glucose monitoring is a valuable tool for managing patients with diabetes in the outpatient settings. Coupling of POCT glucose monitoring devices and electronic medical records enable test results to be shared instantly with care providers. Potential operational benefits with more rapid decision making, reduced operating times, and high-dependency boost the market growth of point-of-care glucose testing.
• Increase in prevalence of diabetic patients, rise in preference for home health care across the globe, and technological advancement done by various key players drive the growth in global level. For instance, GlucoTrack, which is manufactured by Integrity Applications (Israel), performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. As per the WHO, number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. According to a paper published by Massachusetts General Hospital, about 600,000 POC tests per year are performed by physicians and nurses in the institution.

Report Overview: https://www.transparencymarketresearch.com/point-of-care-glucose-testing-market.html

Key Drivers and Restraints of Global Point-of-Care Glucose Testing Market
• Increase in cases of diabetic patients across the world is expected to fuel the market growth. As per an article published in NCBI in 2017, prevalence of diabetes in the U.S. is likely to increase by 54% which is more than 54.9 million, between 2015 and 2030. According to the International Diabetes Federation, global prevalence of diabetes patients in 2019 was approximately 9.3% (463 million people). It is anticipated to rise to 10.2% (578 million) by 2030 and 10.9% (700 million) by 2045. IDF stats also depict that number of diabetes patients in Europe is likely to rise from approximately 33 million in 2010 to 38 million in 2030.
• Technological innovations that provide early, safe, and accurate results for diagnosis tend to make a serious impact in the market. The advanced technology helps in continually updating the market by bringing on better products. Companies are launching technologically advanced devices for hassle-free testing experience. In 2016, Roche launched Accu-Chek Guide blood glucose monitoring system that offers a new spill-resistant SmartPack vial and a unique strip design with a large easy-edge dosing area.
• Accuracy of tests is one of the restraining factors for the market growth. Often, cases of false negative and false positive tests have been reported. This amounts to misdiagnosis even though these tests have been developed after severe R&D.

Reques Broucher: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76299

Meters to Dominate Global Point-of-Care Glucose Testing Market
• Based on product type, the global point-of-care glucose testing market can be divided into strips, lancets & lancing devices, and meters
• The meters segment generated maximum revenue in 2018. In 2018, approximately 1.26 million units of blood glucose meters were sold in the U.S. alone, up from 960 thousand units sold in 2017.
Fingertip to Lead Global Point-of-Care Glucose Testing Market
• Based on testing site, the global point-of-care glucose testing market can be divided into fingertip and alternate site testing
• Fingertip is expected to dominate the global market in terms of revenue generation. Finger-stick blood samples for blood glucose testing is a traditional way of monitoring the glucose level in patients. However, alternate site testing is expected to grow with the highest CAGR during the forecast period, owing to its various advantages over the traditional one such as less pain and sparing of fingertips.
• Accu-Chek FastClix lancing device which is a product of Roche Diabetes Care, Inc. can be used for both alternate sites and fingertip testing

Request Customization: https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=76299

Homecare Settings Segment to Witness Highest Growth
• Based on end-user, the global point-of-care glucose testing market can be divided into professional diagnostic centers, hospitals & clinics, home care settings, and others
• The home care settings segment dominated the global point-of-care glucose testing market. The segment is expected to grow at the highest rate during the forecast period. Rise in demand for home care settings is due to increased acceptance of home health care, technological advancements, and cost-effective alternatives compared to other modalities.
North America to Dominate Global Point-of-Care Glucose Testing Market
• In terms of region, the global point-of-care glucose testing market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
• In terms of revenue, North America dominated the point-of-care glucose testing market and is expected to lead the market position during the forecast period. Growing prevalence of diabetes and other lifestyle disorders, rise in number of product approvals, and increase in government initiatives in this region boost the market growth in this region. According to the American Diabetes Association, approximately 34.2 million people in the U.S., which is 10.5% of the population, had diabetes in 2018.
• Asia Pacific is expected to grow at the highest CAGR in the forecast period. Growing health care facilities and favorable reimbursement policies in developing economies are likely to fuel the market growth in the region in the near future. As per the International Diabetes Federation, over 114,394,800 cases of diabetes were diagnosed in China in 2017.

Pre Book: https://www.transparencymarketresearch.com/checkout.php?rep_id=76299

More Trending Report by Transparency Market Research:

https://www.prnewswire.com/news-releases/contraceptives-market-to-gain-valuation-of-us-2-7-bn-by-2028--notes-study-by-tmr-301473001.html

https://www.prnewswire.com/news-releases/valuation-of-vascular-snare-market-to-reach-us-54-4-mn-by-2031-medtech-companies-offering-new-designs-for-next-gen-devices-notes-tmr-study-301477750.html

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.